DLX-105
DLX-105 is a human monoclonal antibody (mAb) targeting TNFSF2/TNFa. DLX-105 reduces skin epidermal thickness and the expression of K16 and Ki67. DLX-105 down-regulates the mRNA levels of IL-17, TNF-α, IL-23p19, IL-12p40, and IFN-γ. DLX-105 can be used in psoriasis research[1].
Product Specifications
UNSPSC
12352203
Target
IFNAR; Interleukin Related; TNF Receptor
Related Pathways
Apoptosis; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
[DLX-105]
References & Citations
[1]Tsianakas A, et al. The single-chain anti-TNF-α antibody DLX105 induces clinical and biomarker responses upon local administration in patients with chronic plaque-type psoriasis. Exp Dermatol. 2016 Jun;25 (6) :428-33.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6314691-01 0.2 mL
KRT36, NT (KRT36, HHA6, HKA6, KRTHA6, Keratin, type I cuticular Ha6, Hair keratin, type I Ha6, Keratin-36) (Biotin)
Sign In for Pricing
View Details MBS6314691-02 5x 0.2 mL
KRT36, NT (KRT36, HHA6, HKA6, KRTHA6, Keratin, type I cuticular Ha6, Hair keratin, type I Ha6, Keratin-36) (Biotin)
Sign In for Pricing
View Details 
MR202915L4V 200 µL
Tmem150b (NM_001142792) Mouse Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details